Teal Health has raised $8.8M in seed funding from investors, including Emerson Collective, Serena Ventures, Metrodora Ventures, and Felicis Ventures, to build a women’s health platform focused on solving some of the most pressing issues in women’s health – starting with cervical cancer. Teal Health’s at-home cervical cancer screening includes a novel self-collection device that will make it simple for a woman…
Menopause is defined as the final menstrual period and is typically confirmed after a woman has missed her period for 12 consecutive months. Most women experience menopause between ages 40 and 58. An estimated 45 million women in the U.S. are approaching or in menopause, which results in a decrease in estrogen and other hormones. Hot flashes, vaginal dryness and loss of bone density are…
Woebot Health has enrolled the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational digital therapeutic for postpartum depression (PPD) that was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) in 2021. The multi-center, double-blind, randomized controlled study is actively recruiting women ages 22 to 45 who have given birth in the last three…
According to the Office on Women’s Health iron-deficiency anemia affects more women than men. The risk of iron-deficiency anemia is highest for women who are either pregnant or have heavy menstrual periods. Overall more than 80 million people in America alone are at risk of anemia. Anemia testing traditionally requires access to a doctor or a lab, insurance, and needles. Sanguina is…
Tia, the women’s health company pioneering a “whole-woman, whole-life” hybrid care model raised its $100M Series B back in 2021. After expanding its offering to include fertility services, the company is now teaming up with Cedars-Sinai, one of California’s leading health systems, to expand access to primary and specialty care for women across Los Angeles. Together, the two healthcare companies will provide…
This Week’s Highlights Babylist acquires pregnancy media platform Expectful. LEIA Health raises €1.4M in pre-seed funding to reinvent post-pregnancy care for the digital age. Oya Femtech Apparel raises $1.3M in oversubscribed seed funding. Male Contraception Initiative invests $800K in Eppin Pharma to support clinical trials for a non-hormonal contraceptive. Cycle care marketplace startup Unfabled partners with E-Pharmacy; Now offers online pharmacy services. Fermata releases a new femtech market map of Southeast Asia. Amazon launches a $5 monthly subscription for generic drugs. This week’s…
Babylist, the leading vertical marketplace and commerce destination for all things baby, has acquired Expectful, a health and wellness app and media site. Babylist’s established media business provides product recommendations and expert-guided content to over 7.5 million unique visitors each month. This deal will enable Expectful to expand into the leading media site for anyone on the pregnancy journey, providing a one-stop destination…
LEIA Health, a Swedish startup focused on supporting new parents during the Forth Trimester has raised €1.4M in pre-seed funding. The round was led by People Ventures with participation from Norsken, Unconventional Ventures, The Case for Her, and Octaquest. LEIA raised a €600K angel round about a year ago. Out of the 140 million women giving birth each year, 90% will experience…
